title: Pharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institution.
authors.forename: S
authors.initials: S
authors.lastname: Majumdar
authors.forename: A
authors.initials: A
authors.lastname: Ostrenga
authors.forename: R D
authors.initials: RD
authors.lastname: Latzman
authors.forename: C
authors.initials: C
authors.lastname: Payne
authors.forename: Q
authors.initials: Q
authors.lastname: Hunt
authors.forename: A
authors.initials: A
authors.lastname: Morris
authors.forename: R
authors.initials: R
authors.lastname: Iyer
mesh_terms: D000293:Adolescent; D001779:Blood Coagulation Factors / Q000191:economics* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003365:Costs and Cost Analysis; D005260:Female; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy* / Q000191:economics*; D002836:Hemophilia B / Q000150:complications / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D008297:Male; D009765:Obesity / Q000191:economics*; D015431:Weight Loss
chemical_list: D001779:Blood Coagulation Factors